Prepared for
Light
Frequency Research Compounds
Precision sub-cutaneous
preparations. Research grade.
Each compound is aseptically reconstituted, sterile filtered at 0.2 μm PVDF, and gravimetrically filled into pen vials. Tap any card for full research detail and mechanism.
◆ All compounds are for research use only · Not for human therapeutic use · Researcher agreement required
◆ Research & Education Videos
Short — Research Insight
Frequency Research Compounds
How to Prime a Pen
Pen Priming · Getting Started
Best Peptide to Lose Fat — MOTS-c vs GLP-1
MOTS-c · GLP3-Plus
NAD+ vs Methylene Blue — Which is Best?
NAD+
Doctor Reveals 3 Mitochondrial Fixes
Mitochondrial Health
GLP3-Plus — Metabolic Signalling
GLP3-Plus
GLP3-Plus — Full Explainer
GLP3-Plus
Short — Research Insight
Frequency Research Compounds
Short — Research Insight
Frequency Research Compounds
◆ Frequently Asked Questions
◆ Getting Started

All compounds are supplied for personal research purposes only and are not approved for human therapeutic use by any regulatory authority. By submitting an enquiry you confirm your understanding of this research-only status.

The reusable pen has a 60-click graduated barrel. 30 clicks = 0.25ml — the standard dose for most compounds. Each click is precise and consistent. Prime the pen before first use by expelling a small amount before the first injection.

Note: SS-31 uses a 2.25ml fill rather than 3.03ml, giving 9 doses per vial instead of 12. All other compounds give 12 doses per vial at 30 clicks.

Insert the pen needle through the vial septum. Pull the plunger back slowly to the desired click count. Withdraw the needle, tap out any air bubbles, and expel a small amount to confirm flow before injecting. Store the loaded pen tip-down in the refrigerator if not using immediately.

30 clicks = 0.20ml · 3.03ml fill · 0.9% BAC water

CompoundVialConcentrationmg / 30 clicksDoses/vial
MOTS-c20mg6.60mg/ml1.65mg12
BPC-15710mg3.03mg/ml0.83mg12
TB-50010mg3.03mg/ml0.83mg12
SS-3110mg4.44mg/ml1.11mg9 *
GHK-Cu50mg1.515mg/ml0.303mg12
Ipamorelin2mg0.66mg/ml0.17mg (165mcg)12
* SS-31 uses a 2.25ml fill — 9 doses per vial at 30 clicks. All others use 3.03ml fill.
◆ GLP3-Plus Protocol

GLP3-Plus (Retatrutide / LY3437943) simultaneously activates GLP-1, GIP, and glucagon receptors — a triple agonist. Phase 2 trial data: 22.8% mean body weight loss at 8mg/week over 48 weeks.

The protocol runs across three vials over approximately 10 weeks to reach the Phase 2 maintenance dose, then transitions to a monthly subscription:

StageVialWeekly dosesDose rangeDuration
115mg (4.95mg/ml)5 × weekly1 → 2 → 3 → 4 → 5mg5 weeks
230mg (9.90mg/ml)5 × weekly4 → 5 → 6 → 7 → 8mg5 weeks
332mg (32mg/ml)4 × weekly8mg fixedMonthly
Each titration vial is empty at dose 5 — designed as a one-month supply. The 32mg maintenance vial uses a 1.0ml fill: 24 clicks = 0.25ml = 8mg — same pen technique as every other compound. Vial reconstituted and empty within 4 weeks.

Blood sugar caution: GLP3-Plus is a GLP-1/GIP/glucagon triple agonist and can lower blood glucose, particularly at higher doses or with reduced food intake. Keep a fast-acting glucose source on hand — MG-LZ8 Honey Snap Pack is recommended specifically for this: a natural, portable glucose source for if symptoms of low blood sugar appear.

It depends on the compound and your dosing frequency. Here are the typical requirements — full detail is in the Protocols tab:

CompoundTypical cycleVials needed
GLP3-PlusStages 1+2 (10 weeks)1 × 15mg + 1 × 30mg, then 1 × 32mg/month
MOTS-c8–12 weeks daily~5 vials (8 wks) · ~7 vials (12 wks)
BPC-1574–6 weeks~3 vials once daily · ~5–6 twice daily (acute)
TB-5008–12 weeks loading~5 vials loading · 1 vial per 3 months maintenance
SS-318–12 weeks daily~8 vials daily · ~5 vials at 5×/week
GHK-Cu4–8 weeks1 vial per 4 weeks (3×/week at 15 clicks)
Ipamorelin8–12 weeks daily~4 vials per 8-week cycle
◆ The Compounds

MOTS-c is a 16-amino-acid peptide encoded directly in the mitochondrial genome. It activates AMPK — the master metabolic regulator — improving insulin sensitivity, metabolic flexibility, and exercise capacity. Research focus: metabolic recalibration, energy utilisation, longevity signalling. No completed human clinical trials to date — dosing is extrapolated from preclinical models.

BPC-157 is a 15-amino-acid peptide derived from a protective gastric juice protein. It promotes healing across multiple tissue types — gut wall repair, tendon and ligament regeneration, muscle recovery, and angiogenesis via VEGFR2 upregulation. Inject near the injury site where possible. For acute injury: twice daily. For maintenance or gut support: once daily.

TB-500 is a synthetic analogue of Thymosin Beta-4. It promotes actin polymerisation — enabling cell migration to injury sites — accelerating repair across muscle, tendon, ligament, skin, and cardiac tissue. Works systemically: injection site does not need to be near the injury. Often stacked with BPC-157 for comprehensive repair coverage.

SS-31 (Elamipretide) concentrates in the inner mitochondrial membrane, binding cardiolipin — critical to the electron transport chain. It stabilises crista architecture, reduces mitochondrial ROS, and restores ATP production efficiency. FDA granted accelerated approval in 2025 for Barth syndrome — the first approved mitochondrial membrane-targeted therapy.

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) activates over 4,000 human genes, the majority involved in tissue repair, collagen synthesis, anti-inflammatory regulation, and antioxidant defence. Plasma levels decline from ~200ng/ml at age 20 to under 80ng/ml by age 60. Note: at FRC concentration (1.515mg/ml) the full 30-click dose delivers 0.303mg — use 7 clicks (1mg) or 15 clicks (2mg) for introductory dosing.

Ipamorelin is a pentapeptide ghrelin mimetic that selectively stimulates natural growth hormone release without raising cortisol, ACTH, or prolactin — even at high doses. Half-life approximately 2 hours. Best taken 30–60 minutes before bed on an empty stomach to synergise with the natural nocturnal GH pulse. Standard dose: 30 clicks = 0.25ml = 165mcg.

NAD+ is the master coenzyme of cellular energy metabolism, central to over 500 enzymatic reactions and the essential cofactor for sirtuins (SIRT1–7) governing DNA repair, circadian rhythm, and cellular senescence. NAD+ levels decline by approximately 50% between ages 40 and 60.

GanodermaGOLD™ is built on MG-LZ8 — a proprietary Ganoderma sichuanense dual-phase extract that acts as a biological signal calibrator. Chronic inflammation and elevated cortisol create noise that disrupts immune communication. MG-LZ8 lowers that noise floor by supplying 5 of the 8 essential glyconutrients that build the glycoproteins immune cells use to signal each other.

Stacked with peptides, it ensures the signalling environment is clean enough for peptide instructions to land clearly. Particularly relevant with GLP3-Plus — reducing inflammatory baseline before starting a metabolic protocol improves response consistency significantly.

The noise reduction is genuinely dramatic, not a marginal effect. Pre-clinical data (Vetvicka, University of Louisville, 2018) recorded IL-2 cytokine production rising from 1.1 to 262.4 pg/ml at 100μg — a 238× increase, alongside phagocytosing neutrophils rising from a 31.1% baseline to 47.2% within 24 hours (+51.7%). Zero cytotoxicity was confirmed across four separate cancer cell lines at all doses tested. Prof. Vetvicka is the world's leading researcher in beta-glucan immunology, with over 300 peer-reviewed publications on immune modulation.

On safety specifically: no lethal dose has been established for MG-LZ8 (LD50 = 0) — testing has not identified a dose at which toxicity occurs. Independent heavy metals analysis confirmed all heavy metals below the limit of detection, with zero detectable starch and zero pathogens.

One genuine consideration: MG-LZ8 contains a fibrinolytic enzyme (Mr 52,000) with natural blood-thinning activity. If you are on a pharmaceutical anticoagulant (warfarin, heparin, aspirin therapy), consult your prescribing physician before use. All other concurrent use is generally safe — this is a consideration to be aware of, not a barrier to daily use.

TTD is the maximum-strength format in the MG-LZ8 range — a high-potency liquid concentrate carried by a pharmaceutical-grade DMSO base with patented CHD-FA™ fulvic acid, delivering 2.4g of MG-LZ8 per 30ml bottle directly into the bloodstream, bypassing digestive degradation entirely.

Chronic inflammation and elevated cortisol create biological noise that disrupts how immune cells communicate. MG-LZ8 lowers that noise floor by supplying 5 of the 8 essential glyconutrients (mannose, fucose, xylose, glucose, galactose) — the literal building blocks of the glycoproteins and glycoforms cells use to signal each other. These structures are recognised by Dectin-1 and Toll-like receptors on innate immune cells, converting a structural signal into an active response. This is the FirstSignal principle: a clearer signal, less noise, more coherent biological communication.

Independently validated pre-clinical data (Vetvicka, University of Louisville, 2018): phagocytosing neutrophils rose from a 31.1% baseline to 47.2% within 24 hours (+51.7%), alongside a 238× increase in IL-2 signalling, with zero cytotoxicity recorded.

Capsules are the daily oral foundation of the MG-LZ8 range — the simplest entry point, and the recommended starting layer to run alongside any peptide protocol. Each 15mg capsule is concentrated from a 12× more potent Antler-grown source with a further 29-fold dual-extraction yield, equal to 5,400mg of standard imported Reishi powder.

The mechanism is the same across the whole range: chronic inflammation and cortisol create biological noise that interferes with immune signalling. MG-LZ8 supplies 5 of the 8 essential glyconutrients that build the glycoproteins and glycoforms cells use to communicate, recognised through the Dectin-1 and TLR pathway — lowering the noise floor so the body's own signalling — its FirstSignal — comes through clearly.

Pre-clinical data (Vetvicka, 2018) recorded a +51.7% rise in phagocytosing neutrophils and a 238× increase in IL-2 signalling, with zero cytotoxicity. One capsule daily, systemic support.

The same noise-reducing MG-LZ8 mechanism as the rest of the range, in a mess-free single-serving format — 8mg of MG-LZ8 dual extract per 7g pack, paired with pure, naturally settled Cape Eucalyptus honey. Snap, squeeze into the mouth or a beverage, no water required.

MG-LZ8 supplies 5 of the 8 essential glyconutrients (mannose, fucose, xylose, glucose, galactose) that build the glycoproteins and glycoforms driving cell-to-cell communication, recognised via the Dectin-1/TLR pathway — the same +51.7% neutrophil activation and 238× IL-2 response documented across the range (Vetvicka, 2018). A practical first step into the range, or a convenient travel companion for existing researchers. Vegan, organic, non-GMO.

GLP3-Plus companion: if you're running a GLP3-Plus protocol, keep a pack on hand — a natural, fast-acting glucose source for if symptoms of low blood sugar appear.

The Skin Serum is a medical-grade transdermal topical — not a cosmetic product. A 20% pharmaceutical-grade DMSO carrier transports 24mg of MG-LZ8 Antler Reishi dual extract directly through the skin barrier into the lymphatic system and cellular tissue.

For peptide users specifically: people using this product report that subcutaneous bumps and nodules from sub-cut injections — often caused by particulate (“noise”) in the injected liquid — visibly reduce with regular use, with firmer, longer-standing bumps reported reduced to roughly 10% of original size after about 4 weeks. These bumps can otherwise persist for months, or never fully resolve on their own.

Beyond injection site recovery, reported uses include lymphatic support (congested or swollen nodes), joint and nerve inflammation, advanced wound care, and dermatological recovery. Apply 1–2 pumps directly to the affected area and allow to dry fully.

◆ Storage & Logistics

Unopened (lyophilised): refrigerate at 2–8°C. Keep away from direct light. Do not freeze.
After reconstitution: refrigerate at 2–8°C. Use within 4–6 weeks. Do not freeze the reconstituted solution — this degrades the peptide.
Allow vials to reach room temperature before opening to reduce condensation. Store the loaded pen tip-down in the fridge between doses.

Submit your selection using the enquiry form below. You will receive an invoice with EFT banking details and a reference number.

Delivery OptionAreaCost
Cape Town & Surrounds50km radiusR 150
National DeliveryAnywhere in SAR 200
CollectionStrand, Western CapeFree
◆ Compound Protocols
Targeted Therapy MG-LZ8 TTD — Targeted Therapy Drops
Vial30ml
MG-LZ82.4g
CarrierCHD-FA™
FormatDrops
8 drops, 2×/day · In 50ml water · CHD-FA™ fulvic acid transport
Chronic inflammation and elevated cortisol generate constant biological noise — static that drowns out the signals cells use to coordinate immune response and communicate with one another. MG-LZ8 is a signal clarifier, not a stimulant: it lowers that noise floor directly. Of the eight essential glyconutrient sugars required to build the glycoproteins and glycoforms responsible for cell-to-cell communication, five are confirmed present in the MG-LZ8 fraction — mannose, fucose, xylose, glucose, and galactose. These are the literal building blocks of the signalling molecules immune cells use to recognise threats and coordinate a response. The recognition pathway runs through Dectin-1 and Toll-like receptors (TLRs) — pattern-recognition receptors on innate immune cells that bind the beta-glucan and glycoform structures MG-LZ8 supplies, triggering the downstream signalling cascade. This is the FirstSignal principle: your body already knows what to do — MG-LZ8’s role is making sure the message arrives clearly.
Independently validated pre-clinical data (Vetvicka, University of Louisville, 2018): phagocytosing neutrophils rose from a 31.1% baseline to 47.2% within 24 hours at the 100μg dose (+51.7%), alongside a 238× increase in IL-2 signalling — with zero cytotoxicity recorded. TTD delivers this at maximum strength: a high-potency liquid concentrate carried by a pharmaceutical-grade DMSO base with patented CHD-FA™ fulvic acid, increasing cell membrane permeability so MG-LZ8 bypasses digestive degradation and reaches the bloodstream directly.
Daily Foundation MG-LZ8 Capsules — Daily Immune Modulator
Vial30 caps
MG-LZ815mg/cap
FormatCapsule
Daily1×/day
1 capsule daily · Systemic immune & metabolic support · Foundation layer
Chronic inflammation and elevated cortisol create biological noise — static that interferes with the signals immune cells rely on to communicate clearly. MG-LZ8 lowers that noise floor at the source: it supplies 5 of the 8 essential glyconutrients (mannose, fucose, xylose, glucose, galactose) required to build the glycoproteins and glycoforms that carry cell-to-cell signals. These sugars are recognised by Dectin-1 and Toll-like receptors on innate immune cells — the pattern-recognition pathway that converts a structural signal into an active immune response. This is the foundation of the FirstSignal principle: your body’s own biological signalling system, working with less static, more coherence, and a clearer signal-to-noise ratio.
Pre-clinical data (Vetvicka, University of Louisville, 2018) recorded phagocytosing neutrophils rising from a 31.1% baseline to 47.2% within 24 hours (+51.7%), alongside a 238× increase in IL-2 signalling, with zero cytotoxicity. Each 15mg capsule is concentrated from a 12× more potent Antler-grown source with a further 29-fold dual-extraction yield — equal to 5,400mg of standard imported Reishi powder. Capsules are the simplest daily entry point into the range, and the recommended foundation to run alongside any peptide protocol — a clean signalling environment before adding metabolic or structural peptide instructions on top.
On-The-Go MG-LZ8 Honey — On-The-Go Format
Vial30 packs
MG-LZ88mg/pack
FormatSnap Pack
Daily1×/day
1 pack daily · Snap, squeeze into mouth or beverage · No water required
The same noise-reducing mechanism as the rest of the MG-LZ8 range, in a mess-free daily format. Inflammation and cortisol create biological static that disrupts how immune cells communicate; MG-LZ8 supplies 5 of the 8 essential glyconutrients — mannose, fucose, xylose, glucose, galactose — that build the glycoproteins and glycoforms cells use to signal one another, recognised through the Dectin-1 and TLR pathway. Clearer signal, less noise: the FirstSignal principle in its most convenient format.
Independent testing recorded the same pronounced IL-2 response (238×) and neutrophil activation (+51.7%, Vetvicka 2018) behind every format in the range. Each 7g pack pairs 8mg of MG-LZ8 dual extract with pure, naturally settled Cape Eucalyptus honey — combining the calibrating effect with natural energy and antibacterial properties. Vegan, organic, non-GMO, and 100% bio-available. A practical first step into the range, or a convenient travel companion for existing researchers.
GLP3-Plus companion: keep a pack on hand if you are running a GLP3-Plus protocol. As a GLP-1/GIP/glucagon triple agonist, GLP3-Plus can lower blood glucose — this is a natural, fast-acting glucose source for if symptoms of low blood sugar appear.
Topical MG-LZ8 Skin Serum — Transdermal Delivery
Vial30ml
MG-LZ824mg
DMSO20%
FormatPump
1–2 pumps · Massage onto clean, affected area · Allow to dry fully
Injection site recovery: People using this product report that subcutaneous bumps and nodules from sub-cut injections — often caused by particulate (“noise”) in the injected liquid — visibly reduce with regular use, with firmer, longer-standing bumps reported reduced to roughly 10% of original size after about 4 weeks of use. These bumps can otherwise persist for months, or never fully resolve on their own.
Broader reported uses: lymphatic support (congested or swollen nodes), joint and nerve inflammation, advanced wound care (burns, open wounds), and dermatological recovery (new tattoos, moles, skin tags). The DMSO carrier transports MG-LZ8 directly through the skin barrier into the lymphatic system and cellular tissue.
Stage 1 15mg Starter Vial
Conc4.95mg/ml
Fill3.03ml
Doses5 × weekly
Duration5 weeks
DoseWeekmgClicksml
1Week 11mg120.10ml
2Week 22mg240.20ml
3Week 33mg360.30ml
4Week 44mg480.40ml
5Week 55mg600.50ml
◆ Recommended Stack
GLP3-Plus 15mg — weekly SC injection per schedule above
GanodermaGOLD™ Capsules — 1 daily · lowers inflammatory baseline before metabolic protocol
Autoimmune condition present? Replace capsules with Targeted Therapy Drops
Vial is empty at dose 5. Linear titration — each week increases by 1mg. GI side effects (nausea, delayed gastric emptying) are transient and diminish as the body adapts at each level.
Stage 2 30mg Full Protocol Vial
Conc9.90mg/ml
Fill3.03ml
Doses5 × weekly
Duration5 weeks
Begin immediately after completing the 15mg vial · Same weekly injection day
DoseWeekmgClicksml
1Week 64mg240.24ml
2Week 75mg300.30ml
3Week 86mg360.36ml
4Week 97mg420.42ml
5Week 108mg480.48ml
Vial is empty at dose 5. Ramp begins at 4mg (step-back from 5mg end of Stage 1 — allows body to recalibrate on new concentration). Ends at 8mg — Phase 2 trial maintenance dose.
Stage 3 32mg Maintenance Vial
Conc32mg/ml
Fill1.0ml
Doses4 × weekly
Duration4 weeks
Begin week 11 · Fixed dose · Monthly subscription vial
DoseSchedulemgClicksml
1–4Weekly8mg300.25ml
24 clicks = 0.25ml = 8mg — same pen technique as every other compound. Vial reconstituted and empty within 4 weeks. Monthly subscription cadence. Phase 2 trial data: 22.8% mean body weight loss at 8mg/week over 48 weeks (Retatrutide / LY3437943).
Blood sugar caution: as a GLP-1/GIP/glucagon triple agonist, GLP3-Plus can lower blood glucose — particularly at higher doses, later in the day, or when combined with reduced food intake. Keep a fast-acting glucose source on hand. MG-LZ8 Honey Snap Pack is recommended specifically for this — a natural, portable glucose source that can be taken quickly if symptoms of low blood sugar (shakiness, sweating, light-headedness) appear.
Protocol MOTS-c — Daily Titration
Vial20mg
Conc6.60mg/ml
Fill3.03ml
Doses20/vial
18 clicks = 0.15ml = 0.990mg · Daily SC · Before exercise or morning fasted
PhaseDaily DoseNotes
Weeks 1–2800mcg (15 clicks)Daily SC — 24 days per vial
Weeks 3–4990mcg (18 clicks)Full dose — 20 days per vial
Cycle4 weeks titration. To continue, repeat at 990mcg on a 4 weeks on · 2 weeks off basis
TimingBefore exercise or morning fasted for best AMPK response
Vials / cycleWeeks 1–2: 1 vial ≈ 24 days. Weeks 3–4 onward: 1 vial ≈ 20 days
No completed human clinical trials — dosing extrapolated from preclinical models. Stack with GanodermaGOLD™ Capsules to lower inflammatory baseline and improve metabolic signal clarity.
Protocol BPC-157 — Repair Protocol
Vial10mg
Conc3.03mg/ml
Fill3.03ml
Doses15/vial
24 clicks = 0.20ml = 0.606mg (606mcg) · SC near injury site where possible
PhaseDoseFrequency
Build404mcg (16 clicks)Once daily SC
Maintenance606mcg (24 clicks)Once daily SC
Cycle4–6 weeks on · 2 weeks off
TimingAny consistent time · No food restriction required
Vials / cycleBuild phase: 1 vial ≈ 23 days. Maintenance phase: 1 vial ≈ 15 days
Build phase: once daily during the initial loading period. Maintenance: once daily ongoing for gut support or long-term repair. Effects reported within days at this dose range. Rotate sites — abdomen, thighs, upper arms.
Protocol TB-500 — Loading & Maintenance
Vial10mg
Conc3.03mg/ml
Fill3.03ml
Doses12/vial
20 clicks = 0.17ml = 0.505mg (505mcg)
PhaseDoseFrequency
Loading500mcg (20 clicks)2×/week SC — 10 weeks
Maintenance1,000mcg (40 clicks)2×/week SC — 5 weeks
CycleLoading 10 weeks · Maintenance 5 weeks. Maintenance dose increases to overcome reduced signal sensitivity over time
Vials / cycleLoading: ≈1 vial covers the full 10-week loading phase. Maintenance: ≈1 vial covers the full 5-week maintenance phase
TB-500 works systemically — injection site does not need to be near the injury. Stack with BPC-157 for comprehensive repair: BPC-157 addresses local tissue and gut, TB-500 drives systemic cell migration. WADA prohibited — not for competitive athletes.
Protocol SS-31 — Mitochondrial Support
Vial10mg
Conc3.30mg/ml
Fill3.03ml
Doses12/vial
30 clicks = 0.25ml = 0.825mg (825mcg)
DoseDaily Support — 825mcg SC daily — standard dose from Day 1
FrequencyDaily SC · 3–5×/week minimum
Cycle8–12 weeks on · 4 weeks off
TimingMorning preferred · Stack with MOTS-c for combined mitochondrial support
Vials / cycle1 vial ≈ 12 days at daily dosing
FDA granted accelerated approval (2025) for SS-31 (elamipretide / Forzinity) for Barth syndrome — first approved mitochondrial membrane-targeted therapy. Clinical trial doses 5–10mg/day — FRC supply at 825mcg/dose is the introductory research range.
Protocol GHK-Cu — Tissue & Gene Regulation
Vial50mg
Conc16.50mg/ml
Fill3.03ml
Doses24/vial
15 clicks = 0.125ml = 2.06mg · High concentration — precise dosing required
ProtocolDoseFrequency
Standard15 clicks = 2.06mgDaily SC
Cycle4–8 weeks on · 2–4 weeks off
TimingAny consistent time · Rotate sites
Vials / cycle1 vial ≈ 24 days at the standard 15-click daily dose
Activates over 4,000 human genes. At FRC concentration (16.50mg/ml) the standard 15-click dose delivers 2.06mg daily.
Protocol Ipamorelin — GH Secretagogue
Vial2mg
Conc0.66mg/ml
Fill3.03ml
Doses12/vial
30 clicks = 0.25ml = 165mcg · Empty stomach · 30–60 min before bed
PhaseDoseClicks
Weeks 1–2100mcg18 clicks
Weeks 3–4150mcg27 clicks
Weeks 5+165mcg30 clicks
Cycle8–12 weeks on · 2–4 weeks off
TimingBedtime · Empty stomach · Avoid food 2h before + 30min after
Vials / cycle~4 vials per 8-week cycle at daily dosing (12 doses/vial ÷ 7 days = ~12 days per vial)
Half-life ~2 hours. Raises no cortisol, ACTH or prolactin at effective doses. Bedtime dosing synergises with natural nocturnal GH pulse. Receptor desensitisation not observed in animal studies.
Tap a compound for research detail · Select to enquire
◆ 100% Natural · GanodermaGOLD™
◆ Research Compounds · Synthetic
No items selected
 
⭡ Selected for enquiry
Add items to your basket above
Estimated total
R 0
Prices exclude delivery
Subject to availability
◆ Submit Enquiry
Your name
Contact number
Email address
Research context / Notes
Sent directly via email · No data stored · Research use only